Facebook
Google+
Vkontakte
УкраїнськаРусский
English
  • Main
  • About us
    • Mission and values of the company
    • Background
    • Pharmaceutical development
    • Manufacture
    • Analytical laboratory
    • Quality system
      • Quality control
    • Partnership
  • Products
    • Active pharmaceutical ingredients
    • Ready-made medicines
  • News
  • Geography of business
    • Ukraine
    • Belarus
    • Russia
    • Kyrgyzstan
    • Kazakhstan
    • Uzbekistan
    • Azerbaijan
  • Pharmacovigilance
  • Contacts

ADENIZ-Trio

Home Cardiology ADENIZ-Trio

Category: Cardiology
  • Description

Description

Product: tablets

active substances: valsartan, amlodipine, hydrochlorothiazide;
1 tablet contains: 160 mg valsartan, amlodipine besylate equivalent to 5 mg amlodipine and 12.5 mg hydrochlorothiazide
or 160 mg of valsartan, amlodipine besylate, equivalent to 10 mg of amlodipine, and 12.5 mg of hydrochlorothiazide;

Excipients: microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silica, magnesium stearate, polyethylene glycol 6000 (macrogol 6000), hypromellose, titanium dioxide (E 171), talc.

Indication.

  • Treatment of essential hypertension in adult patients with blood pressure adequately controlled by a combination of amlodipine, valsartan and hydrochlorothiazide using three separate drugs or two drugs, one of which is a combination.
DOWNLOAD

Related products

  • ALITER, tablets

    Read more
  • AM-ALITER, tablets

    Read more
  • TRI-ALITER, tablets

    Read more
  • ADENIZ-H, tablets

    Read more

93000, Ukraine, Lugansk region. Rubizhne city street. Lenin, 33